US · Healthcare · Medical Care Facilities
EPS came in at 6.64 against a street estimate of 4.60 — a beat of 44.3%.
Analysts rate Tenet Healthcare Corporation a buy (19 buy, 4 hold, 0 sell out of 23) with an average price target of $304.14.
CONFIDENT Tenet delivered strong Q3 growth, raised 2026 EBITDA and free-cash-flow guidance, and expects enterprise EBITDA growth in 2027 excluding $450 million of one-time Conifer transition benefits. Q3 FY26 Management highlighted exchange pressure and Medicaid expansion exposure but did not provide a geographic regional breakdown. Analysts focused on commercial pricing, Medicaid and exchange exposure, Conifer normalization, surgical growth and hospital margin durability. Management emphasized strong payer visibility, cost controls, diversified growth and continued EBITDA growth excluding one-time transition benefits. 2026-10-29…
Full summary in the app.
| Fund | Stake |
|---|---|
| BlackRock Inc | 10.99% |
| T. Rowe Price Associates, Inc. | 10.00% |
| Boston Partners Global Investors, Inc | 5.57% |
| Vanguard Portfolio Management, LLC | 5.33% |
| FMR Inc | 5.02% |
| Vanguard Capital Management, LLC | 4.89% |
| State Street Corp | 3.46% |
| Glenview Capital Management LLC | 2.81% |
| Document | Date |
|---|---|
| Quarterly report · Q3 2026 HEADLINE NUMBERS • Third-quarter 2026 net operating revenues were $5,631 million, up from $5,289 million in the third quarter of 2025. • Nine-month | 2026-10-29 |
| Results announced · Q4 2026 HEADLINE NUMBERS • Third-quarter 2026 net operating revenues were $5,631 million, up 6.5% from $5,289 million in third quarter 2025. • Net income av | 2026-10-29 |
| Material agreement · Q3 2026 TENET HEALTHCARE CORPORATION – 8-K SUMMARY HEADLINE NUMBERS • Company issued $2,000,000,000 in aggregate principal amount of 6.250% senior notes due | 2026-09-22 |
| Reg FD disclosure · Q3 2026 TENET HEALTHCARE CORPORATION – FORM 8-K SUMMARY HEADLINE NUMBERS • Company issuing $2.0 billion in 6.250% senior notes due 2034 • Notes priced on Se | 2026-09-08 |
| Quarterly report · Q2 2026 TENET HEALTHCARE CORPORATION – Q2 2026 10-Q SUMMARY HEADLINE NUMBERS • Net operating revenues (6M 2026): $10,996 million vs. $10,494 million (6M 202 | 2026-07-29 |
| Results announced · Q3 2026 TENET HEALTHCARE CORPORATION – Q2 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Net income available to common shareholders in Q2 2026: $826 million, or | 2026-07-23 |
| Shareholder vote results · Q2 2026 TENET HEALTHCARE CORPORATION – 8-K SUMMARY HEADLINE NUMBERS • Annual Meeting of Shareholders held May 27, 2026 • All 12 director candidates elected | 2026-05-29 |
| Quarterly report · Q1 2026 TENET HEALTHCARE CORPORATION - Q1 2026 SUMMARY HEADLINE NUMBERS • Net operating revenues: $5,368 million (Q1 2026) vs. $5,223 million (Q1 2025) - up | 2026-04-30 |
Readable in the app.
| Announcement | Date |
|---|---|
| Omnibus agreement with CommonSpirit Health regarding Conifer restructuring Tenet Healthcare announced on February 2, 2026, that its 2025 Adjusted EBITDA will reach the upper end of its $4.47-4.57 billion guidance range, indicating strong operational performance. Ad | 2026-02-02 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Tenet Healthcare Corporation — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-11-07.